LEXEO Therapeutics
BioTech/Drugs - New York, NY, US
LEXEO Therapeutics Employees
Peter Graham
Associate Director, Program and Portfolio Management at LEXEO Therapeutics
LEXEO Therapeutics Senior Management
LEXEO Therapeutics Details
LEXEO Therapeutics is a New York City-based, clinical-stage gene therapy company focused on addressing some of the most devastating genetically defined cardiovascular and central nervous system diseases affecting both larger-rare and prevalent patient populations. LEXEO's foundational science stems from partnerships and exclusive licenses with leading academic laboratories at Weill Cornell Medical College and the University of California, San Diego, two preeminent institutions on the cutting edge of gene therapy research. LEXEO is advancing a deep and diverse pipeline of AAV-based gene therapy candidates in rare cardiovascular diseases, APOE4-associated Alzheimer's disease, and CLN2 Batten disease, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization. For more information, please visit www.lexeotx.com.
LEXEO Therapeutics Technologies
Ad Servers
DoubleClick
Email Providers
Mimecast
Load Balancers
Varnish
CMS
Wix
Other
Google Maps